Literature DB >> 17383138

Development of a liquid chromatography/tandem mass spectrometry method for the quantitation of acetylcholine and related neurotransmitters in brain microdialysis samples.

Mei-Yi Zhang1, Zoë A Hughes, Edward H Kerns, Qian Lin, Chad E Beyer.   

Abstract

Monitoring concentrations of acetylcholine (ACh) in specific brain regions is important in understanding disease pathology, as well as in designing and evaluating novel disease-modifying treatments where cholinergic dysfunction is a hallmark feature. We have developed a sensitive and quantitative liquid chromatography/tandem mass spectrometry method to analyze the extracellular concentrations of ACh, choline (Ch) and (3-carboxylpropyl)-trimethylammonium (iso-ACh) in brain microdialysis samples of freely moving animals. One immediate advantage of this new method is the ability to monitor ACh in its free form without having to use a cholinesterase inhibitor in the perfusate. The separation of ACh, Ch, iso-ACh and related endogenous compounds was carried out based on cation exchange chromatography with a volatile elution buffer consisting of ammonium formate, ammonium acetate and acetonitrile. An unknown interference of ACh, which was observed in brain microdialysates from many studies, was well separated from ACh to ensure the accuracy of the measurement. Optimization of electrospray ionization conditions for these quaternary ammonium compounds achieved the limits of detection (S/N=3) of 0.2 fmol for ACh, 2 fmol for Ch and 0.6 fmol for iso-ACh using a benchtop tandem quadrupole mass spectrometer with moderate sensitivity. The limit of quantitation (S/N=10) was 1 fmol for ACh, 3 fmol for iso-ACh and 10 fmol for Ch. This method was selective, precise (<10% R.S.D.), and sensitive over a range of 0.05-10nM for ACh, 0.25-50 nM for iso-ACh and 15-3000 nM for Ch. To demonstrate that the developed method can be applied to monitoring changes in ACh concentrations in vivo, reference agents that have previously been shown to influence ACh levels were studied in rat dorsal hippocampus. This includes the 5-HT6 receptor antagonist, SB-271046, and the cholinesterase inhibitor, donepezil. Moreover, levels of ACh were demonstrated to be sensitive to infusion of tetrodotoxin (TTX) suggesting that the ACh being measured in vivo was of neuronal origin. Collectively, these biological data provided in vivo validation of this analytical method.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383138     DOI: 10.1016/j.jpba.2007.02.024

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  15 in total

1.  Mass spectrometry "sensor" for in vivo acetylcholine monitoring.

Authors:  Peng Song; Neil D Hershey; Omar S Mabrouk; Thomas R Slaney; Robert T Kennedy
Journal:  Anal Chem       Date:  2012-05-24       Impact factor: 6.986

Review 2.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

3.  5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice.

Authors:  Virginie Da Silva Costa-Aze; Anne Quiedeville; Michel Boulouard; François Dauphin
Journal:  Psychopharmacology (Berl)       Date:  2012-02-25       Impact factor: 4.530

4.  NextGen Brain Microdialysis: Applying Modern Metabolomics Technology to the Analysis of Extracellular Fluid in the Central Nervous System.

Authors:  Chi-Ya Kao; Elmira Anderzhanova; John M Asara; Carsten T Wotjak; Christoph W Turck
Journal:  Mol Neuropsychiatry       Date:  2015-04-29

5.  Monitoring enzyme reaction and screening of inhibitors of acetylcholinesterase by quantitative matrix-assisted laser desorption/ionization Fourier transform mass spectrometry.

Authors:  Zhe Xu; Shengjun Yao; Yuanlong Wei; Jing Zhou; Li Zhang; Cuihong Wang; Yinlong Guo
Journal:  J Am Soc Mass Spectrom       Date:  2008-08-15       Impact factor: 3.109

Review 6.  5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease.

Authors:  Neil Upton; Tsu Tshen Chuang; Ann J Hunter; David J Virley
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

7.  Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task.

Authors:  M V King; C H Spicer; A J Sleight; C A Marsden; K C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2008-10-07       Impact factor: 4.530

8.  How does acetylcholine lose trimethylamine? A density functional theory study of four competing mechanisms.

Authors:  Hadi Lioe; Christopher K Barlow; Richard A J O'Hair
Journal:  J Am Soc Mass Spectrom       Date:  2008-09-25       Impact factor: 3.109

9.  Measurement of Acetylcholine in Rat Brain Microdialysates by LC - Isotope Dilution Tandem MS.

Authors:  L Prokai; P Fryčák; S M Stevens; V Nguyen
Journal:  Chromatographia       Date:  2008-10       Impact factor: 2.044

Review 10.  Review of recent advances in analytical techniques for the determination of neurotransmitters.

Authors:  Maura Perry; Qiang Li; Robert T Kennedy
Journal:  Anal Chim Acta       Date:  2009-09-01       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.